acridines has been researched along with Remission, Spontaneous in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benjamin, RS; Bodey, GP; Burgess, MA; Gutterman, JU; Hall, SW; Legha, SS; Valdivieso, M | 1 |
Chiuten, DF; Gormley, PE; Lichtenfeld, JL; Scoltock, M; Van Echo, DA; Wiernik, PH | 1 |
Krawczyk, K; Pawlicki, M | 1 |
Dobryszycka, W; Gerber, J; Jablonski, K; Osada, J | 2 |
Swiecki, J; Wieczorkiewicz, A | 1 |
Swiecki, J | 1 |
7 other study(ies) available for acridines and Remission, Spontaneous
Article | Year |
---|---|
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.
Topics: Acridines; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Bone Marrow; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Phenylenediamines; Remission, Spontaneous | 1978 |
Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule.
Topics: Acridines; Aged; Antineoplastic Agents; Bone Marrow; Drug Evaluation; Female; Humans; Kinetics; Male; Middle Aged; Neoplasms; Phenylenediamines; Remission, Spontaneous | 1979 |
[Results of therapeutic use of ledakrin in cancer-induced pleural effusion].
Topics: Acridines; Adult; Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Nitracrine; Pleural Effusion; Remission, Spontaneous | 1979 |
Biochemical blood studies in patients with carcinoma of the ovaries during treatment with preparation C-283. I. Behavior of serum protein fractions.
Topics: Acridines; Adenocarcinoma; Alpha-Globulins; Ascites; Blood Proteins; Cystadenocarcinoma; Electrophoresis, Paper; Female; gamma-Globulins; Humans; Ovarian Neoplasms; Remission, Spontaneous; Serum Albumin | 1971 |
Therapeutic efficacy of compound C-283 in patients with mammary carcinoma.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Dimethylamines; Drug Evaluation; Erythrocytes; Female; Humans; Injections, Intravenous; Kidney Function Tests; Leukocytes; Liver Function Tests; Nitro Compounds; Phlebitis; Remission, Spontaneous; Urine; Vomiting | 1973 |
Biochemical studies of cancer patients treated with acridine derivative (C-283). IV. Changes in the levels of serum haptoglobin and sialic acid.
Topics: Acridines; Adenocarcinoma; Adenocarcinoma, Papillary; Antineoplastic Agents; Ascites; Ascitic Fluid; Carcinoma; Cystadenocarcinoma; Cystadenoma; Dimethylamines; Dysgerminoma; Female; Haptoglobins; Humans; Injections, Intraperitoneal; Injections, Intravenous; Neuraminic Acids; Nitro Compounds; Ovarian Neoplasms; Remission, Spontaneous; Teratoma | 1973 |
[C-283 in the treatment of pleural and peritoneal effusions in cases of ovarian cancer].
Topics: Acridines; Ascites; Evaluation Studies as Topic; Female; Humans; Nitro Compounds; Ovarian Neoplasms; Pleural Effusion; Propylamines; Remission, Spontaneous | 1971 |